Award
National Cancer Institute 1R15CA290568-01
Harnessing the potential of pharmacological small molecules to amplify VSV-based oncolytic viral therapy
Recipient
Jean Christopher Chamcheu
Award Amount
$408,966.00
Ceiling
$408,966.00
Awarded
July 05, 2024
Identifier
1R15CA290568-01
NIH awarded a multiyear grant to support research on enhancing VSV-based oncolytic viral therapy using pharmacological small molecules, focusing on melanoma treatment and biomedical research development.
Description
This NIH grant supports research on oncolytic viral therapy for melanoma, involving pharmacological small molecules, engineered viruses, and preclinical models. The project emphasizes biomedical research, student training, and infrastructure development.